Journey Medical Corp (DERM)
3.93
+0.13
(+3.42%)
USD |
NASDAQ |
May 31, 16:00
3.93
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | -5.00M |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
Date | Value |
---|---|
June 30, 2022 | 0.00 |
March 31, 2022 | -20.00M |
December 31, 2021 | -1.20M |
September 30, 2021 | -8.80M |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-20.00M
Minimum
Mar 2022
--
Maximum
Mar 2021
-2.692M
Average
--
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
Fortress Biotech Inc | 0.00 |
Stereotaxis Inc | 0.00 |
GT Biopharma Inc | 5.034M |
Cara Therapeutics Inc | 25.95M |
FibroGen Inc | 51.28M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -5.019M |
Cash from Financing (Quarterly) | 1.637M |
Free Cash Flow | 1.177M |
Free Cash Flow Per Share (Quarterly) | -0.254 |
Free Cash Flow to Equity (Quarterly) | -5.081M |
Free Cash Flow to Firm (Quarterly) | -4.688M |
Free Cash Flow Yield | 1.53% |